In fact, it has been reported that IL-6 inhibits anticancer immune responses generated by cytotoxic chemotherapy (89), and promotes breast cancer metastasis suppressing the anti-tumor immune response via IL-6/JAK/STAT3 signaling (90). Here, IL6 is linked to breast carcinoma.